Author:
Liau Siong-Seng,Qureshi M. Saeed,Praseedom Raaj,Huguet Emmanuel
Abstract
Abstract
Introduction
Hepatic adenomas (HAs) are benign tumors of the liver, which can be solitary or multiple, and have a definite risk of malignant degeneration.
Discussion
The pathogenesis and natural history of this disease entity were previously unknown. Recent research into the molecular pathogenesis of this condition has provided evidence for the malignant transformation of some of these adenomas. In the current article, we discuss the current evidence on the molecular biology underlying malignant transformation of hepatic adenomas and the implications for the surgical management of this disease.
Publisher
Springer Science and Business Media LLC
Reference102 articles.
1. Flejou JF, Barge J, Menu Y, Degott C, Bismuth H, Potet F, Benhamou JP. Liver adenomatosis. An entity distinct from liver adenoma? Gastroenterology 1985;89(5): 1132–1138.
2. Bioulac-Sage P, Balabaud C, Bedossa P, Scoazec JY, Chiche L, Dhillon AP, Ferrell L, Paradis V, Roskams T, Vilgrain V, Wanless IR, Zucman-Rossi J. Pathological diagnosis of liver cell adenoma and focal nodular hyperplasia: Bordeaux update. Journal of hepatology 2007;46(3): 521–527.
3. van der Windt DJ, Kok NF, Hussain SM, Zondervan PE, Alwayn IP, de Man RA, JN IJ. Case-orientated approach to the management of hepatocellular adenoma. Br J Surg 2006; 93(12): 1495–1502.
4. Ball C, Sackett D, Phillips B, Haynes B, Straus S. Levels of evidence and grades of recommendations. In: EBM (Web site of the Oxford Centre for Evidence-Based Medicine); 2009, http://www.cebm.net/
5. Jeannot E, Wendum D, Paye F, Mourra N, de Toma C, Flejou JF, Zucman-Rossi J. Hepatocellular adenoma displaying a HNF1alpha inactivation in a patient with familial adenomatous polyposis coli. Journal of Hepatology 2006;45(6): 883–886.
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献